Intrinsic Value of S&P & Nasdaq Contact Us
English English 中文(简) 中文(简) 中文(繁) 中文(繁) हिन्दी हिन्दी Español Español 日本語 日本語 한국어 한국어 Deutsch Deutsch Français Français
← Back to all stocks

Khiron Life Sciences Corp. KHRNF OTC

Other OTC • Healthcare • Drug Manufacturers - Specialty & Generic • CA • USD

SharesGrow Score
36/100
0/5 Pass
SharesGrow Intrinsic Value
N/A
Negative cash flow

Khiron Life Sciences Corp. (KHRNF) is a Drug Manufacturers - Specialty & Generic company in the Healthcare sector, currently trading at $0.00. It has a SharesGrow Score of 34/100, indicating a weak investment profile with 0 out of 7 criteria passed.

Financials: revenue is $13M, +339.3%/yr average growth. Net income is $33M (loss), growing at -29.2%/yr. Net profit margin is -258.9% (negative). Gross margin is 49.8% (+16.5 pp trend).

Balance sheet: total debt is $2M against $33M equity (Debt-to-Equity (D/E) ratio 0.07, conservative). Current ratio is 3.08 (strong liquidity). Debt-to-assets is 5.3%. Total assets: $42M.

SharesGrow 7-Criteria breakdown: Value ?/100 (Fail), Growth 58/100 (Partial), Past 0/100 (Fail), Health 67/100 (Partial), Moat 43/100 (Fail), Future ?/100 (Fail), Income 10/100 (Fail).

KHRNF SharesGrow Score Overview

45/100
SharesGrow Score
Mixed signals — some strengths
View full scorecard →
VALUE 0/100
Valuation — P/E, PEG, Forward PEG
GROWTH 58/100
Financials — average growth
PAST 0/100
strong — trend
HEALTH 67/100
Balance sheet — Debt-to-Equity (D/E) ratio, Current ratio is
MOAT 43/100
Gross margin is + market cap
FUTURE 0/100
Analyst outlook — as buy
INCOME 10/100
Net profit margin is
Scores derived from financial statements, analyst ratings, and balance sheet data.

Score Breakdown — KHRNF

—
VALUE N/A
N/A
No analyst coverage available for this stock.
~
GROWTH Partial
58/100
KHRNF: +339.3%/yr revenue is, -29.2%/yr Net income is average growth. mixed. Score: >20%/yr = 100, >10% = 80, >5% = 65, >0% = 45, < 0 = 15.
View details →
—
PAST N/A
N/A
No analyst coverage available for this stock.
~
HEALTH Partial
67/100
Balance sheet KHRNF: Debt-to-Equity (D/E) ratio 0.07 (conservative), Current ratio is 3.08 (strong liquidity). Debt-to-Equity < 0.5, Current Ratio > 1.5, Interest Coverage > 8x = ideal. ≥ 70 = Pass.
View details →
✗
MOAT Fail
43/100
KHRNF: Gross margin is 49.8% (+16.5 pp trend), N/A market cap. Moat (0-100): margin (35%) + trend (15%) + market cap (30%) + revenue is (20%). Score 43/100. ≥ 70 = Pass.
View details →
—
FUTURE N/A
N/A
No analyst coverage available for this stock.
✗
INCOME Fail
10/100
KHRNF: Net profit margin is -258.9%. negative. Score: ≥30% = 100, ≥20% = 85, ≥15% = 70, ≥10% = 55, ≥5% = 45, ≥0% = 30, < 0 = 10.
View details →

Stock Chart & Stats

Market Data
52-Week Range0.000001-0.00001
Volume15.04K
Avg Volume (30D)24.17K
Market Cap$2.32K
Beta (1Y)5.43
Share Statistics
EPS (TTM)-0.20
Shares Outstanding$164.52M
IPO Date2021-01-08
Employees310
CEOAlvaro Francisco Torres
Financial Highlights & Ratios
Revenue (TTM)$12.8M
Gross Profit$6.37M
EBITDA$-32.03M
Net Income$-33.13M
Operating Income$-19.79M
Total Cash$8.92M
Total Debt$2.23M
Net Debt$-6.7M
Total Assets$42.27M
Price / Earnings (P/E)-0
Price / Sales (P/S)0
Analyst Forecast
Company Info
CountryCA
ExchangeOther OTC
CurrencyUSD
ISINCA49374L3065

Price Chart

Track all markets on TradingView
KHRNF
Khiron Life Sciences Corp. ↗  ·  Other OTC
Healthcare • Drug Manufacturers - Specialty & Generic
0.00 52WK RANGE 0.00

People Also View

CBWTF
CBWTF
Auxly Cannabis Group Inc.
$0.10
+6.22%
 COPHF
COPHF
Creso Pharma Limited
$0.12
+0.00%
 GRUSF
GRUSF
Grown Rogue International Inc.
$0.32
+0.75%
 RAMMF
RAMMF
RAMM Pharma Corp.
$0.06
+0.00%
 BFRI
BFRI
Biofrontera Inc.
$1.06
-2.75%
 CNPOF
CNPOF
RIV Capital Inc.
$0.08
+0.00%
 PCLOF
PCLOF
PharmaCielo Ltd.
$0.04
+0.72%
 BCBCF
BCBCF
The BC Bud Corporation
$0.04
-3.31%
Contact Us
🎓
SharesGrow Academy
Learn how to calculate Intrinsic Value and find undervalued stocks.
Weekly live sessions
📧 [email protected]
📞 +65 8912 8000
Send us a message